New Zealand markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
156.49+5.51 (+3.65%)
At close: 04:00PM EST
158.36 +1.87 (+1.19%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 62.49B
Enterprise value 60.11B
Trailing P/E 7.35
Forward P/E 7.55
PEG ratio (5-yr expected) 0.06
Price/sales (ttm)3.99
Price/book (mrq)6.32
Enterprise value/revenue 4.36
Enterprise value/EBITDA 5.67

Trading information

Stock price history

Beta (5Y monthly) -1.38
52-week change 342.47%
S&P500 52-week change 317.58%
52-week high 3464.00
52-week low 390.29
50-day moving average 3258.32
200-day moving average 3260.00

Share statistics

Avg vol (3-month) 33.49M
Avg vol (10-day) 33.5M
Shares outstanding 5242.52M
Implied shares outstanding 6N/A
Float 877.89M
% held by insiders 166.88%
% held by institutions 117.26%
Shares short (30 Dec 2021) 42.16M
Short ratio (30 Dec 2021) 40.69
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 40.89%
Shares short (prior month 29 Nov 2021) 42.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 54.34%
Operating margin (ttm)74.25%

Management effectiveness

Return on assets (ttm)81.62%
Return on equity (ttm)155.47%

Income statement

Revenue (ttm)13.79B
Revenue per share (ttm)56.59
Quarterly revenue growth (yoy)8,918.20%
Gross profit (ttm)-222.04M
Net income avi to common (ttm)7.49B
Diluted EPS (ttm)31.60
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.39B
Total cash per share (mrq)9.8
Total debt (mrq)286.7M
Total debt/equity (mrq)3.29
Current ratio (mrq)2.76
Book value per share (mrq)35.65

Cash flow statement

Operating cash flow (ttm)1.34B
Levered free cash flow (ttm)-54.75M